A phase II study of temozolomide in hormone-refractory prostate cancer

JP van Brussel, MB Busstra, MS (Margreet) Lang, T Catsburg - Wittebol, Fritz Schröder, GHJ Mickisch

Research output: Contribution to journal › Article › Academic › peer-review

33 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	509-512
Number of pages	4
Journal	Cancer Chemotherapy & Pharmacology
Volume	45
Publication status	Published - 2000

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{35fb929c98bd45e5a4c3d5b333d92f5e,

title = "A phase II study of temozolomide in hormone-refractory prostate cancer",

author = "{van Brussel}, JP and MB Busstra and Lang, {MS (Margreet)} and {Catsburg - Wittebol}, T and Fritz Schr{\"o}der and GHJ Mickisch",

year = "2000",

language = "Undefined/Unknown",

volume = "45",

pages = "509--512",

journal = "Cancer Chemotherapy & Pharmacology",

issn = "0344-5704",

publisher = "Springer Science+Business Media",

}

TY - JOUR

T1 - A phase II study of temozolomide in hormone-refractory prostate cancer

AU - van Brussel, JP

AU - Busstra, MB

AU - Lang, MS (Margreet)

AU - Catsburg - Wittebol, T

AU - Schröder, Fritz

AU - Mickisch, GHJ

PY - 2000

Y1 - 2000

M3 - Article

SN - 0344-5704

VL - 45

SP - 509

EP - 512

JO - Cancer Chemotherapy & Pharmacology

JF - Cancer Chemotherapy & Pharmacology

ER -